Mefloquine

Breastfeeding
  • TRADE NAMES: Lariam (Roche); Laricam; Mephaquin; Mephaquine
  • INDICATIONS: Malaria
  • CLASS: Antimalarial, Antiprotozoal
  • HALF-LIFE: 21–22 days
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Acebutolol, Artemether/Lumefantrine, Ethosuximide, Halofantrine, Ketoconazole, Lacosamide, Moxifloxacin, Oxcarbazepine, Quinine, Tiagabine, Typhoid Vaccine, Vigabatrin

PREGNANCY CATEGORY: C

NEUROPSYCHIATRIC ADVERSE REACTIONS

See full prescribing information for complete boxed warning.

Our database has 79 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
HAIR
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
ENDOCRINE/METABOLIC
GASTROINTESTINAL/HEPATIC
HEMATOLOGIC
NEUROMUSCULAR/SKELETAL
OCULAR
OTIC
RESPIRATORY
OTHER


Page last updated 11/28/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top